Harvard Bioscience (HBIO) Work In Process (2011 - 2026)

Harvard Bioscience (HBIO) has 16 years of Work In Process data on file, last reported at $3.4 million in Q1 2026.

• Work In Process for Q1 2026 came in at $3.4 million, up 11.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (up 11.4% YoY), and the FY2025 annual result was $3.3 million, up 18.45% from the prior year.
• Work In Process grew to $3.4 million in Q1 2026 per HBIO's latest filing, from $3.3 million in the prior quarter.
• Over five years, Work In Process peaked at $4.6 million in Q3 2023 and troughed at $1.6 million in Q2 2025.
• A 5-year average of $3.4 million and a median of $3.4 million in 2022 frame the typical range for Work In Process.
• The sharpest annual moves came in 2023 and 2025: Work In Process advanced 20.7% in 2023, then tumbled 52.79% in 2025.
• A 5-year view of Work In Process shows it stood at $3.8 million in 2022, then rose by 10.91% to $4.2 million in 2023, then sank by 34.24% to $2.8 million in 2024, then increased by 18.45% to $3.3 million in 2025, then increased by 3.03% to $3.4 million in 2026.
• Business Quant data shows HBIO's Work In Process at $3.4 million in Q1 2026, $3.3 million in Q4 2025, and $2.3 million in Q3 2025.